309 related articles for article (PubMed ID: 12010368)
1. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
[TBL] [Abstract][Full Text] [Related]
2. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
Terada T; Nakanuma Y
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Nakopoulou L; Stefanaki K; Vourlakou C; Manolaki N; Gakiopoulou H; Michalopoulos G
Pathol Res Pract; 1999; 195(1):19-24. PubMed ID: 10048090
[TBL] [Abstract][Full Text] [Related]
5. Analysis of proliferating biliary epithelial cells in human liver disease using a monoclonal antibody against DNA polymerase alpha.
Seki S; Sakaguchi H; Kawakita N; Yanai A; Kuroki T; Kobayashi K
Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):133-43. PubMed ID: 7682020
[TBL] [Abstract][Full Text] [Related]
6. Determination of tumor marker levels in cystic fluid of benign liver cysts.
Iwase K; Takenaka H; Oshima S; Yagura A; Nishimura Y; Yoshidome K; Tanaka T
Dig Dis Sci; 1992 Nov; 37(11):1648-54. PubMed ID: 1385056
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma.
Machinami R; Oono Y
Virchows Arch A Pathol Anat Histopathol; 1987; 412(2):111-8. PubMed ID: 2827370
[TBL] [Abstract][Full Text] [Related]
8. Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Lake-Bakaar G; Mazzoccoli V; Ruffini L
Dig Dis Sci; 2002 Jul; 47(7):1644-8. PubMed ID: 12141830
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
Ohshio G; Ogawa K; Kudo H; Yamabe H; Nakashima Y; Kim YC; Endo K; Watanabe Y; Manabe T; Tobe T
J Gastroenterol Hepatol; 1990; 5(1):25-31. PubMed ID: 2103381
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
[TBL] [Abstract][Full Text] [Related]
12. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.
Maestranzi S; Przemioslo R; Mitchell H; Sherwood RA
Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():99-103. PubMed ID: 9463746
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung.
Ohshio G; Yamaki K; Imamura T; Suwa H; Chang CY; Wada H; Sueno Y; Imamura M
Tumori; 1995; 81(1):67-73. PubMed ID: 7754546
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues.
Nakajima T; Kagawa K; Ueda K; Ohkawara T; Kimura H; Kakusui M; Deguchi T; Okanoue T; Kashima K; Ashihara T
J Gastroenterol; 1994 Aug; 29(4):450-4. PubMed ID: 7951855
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of proliferating cell nuclear antigen in autoimmune hepatitis in a patient with raised serum concentration of CA19-9.
Sohda T; Iwata Y; Shijo H; Egashira Y; Egashira K; Okumura M
J Clin Pathol; 1998 Feb; 51(2):167-9. PubMed ID: 9602695
[TBL] [Abstract][Full Text] [Related]
17. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
Terada T; Hoso M; Nakanuma Y
Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
[TBL] [Abstract][Full Text] [Related]
18. Detection of an oncofetal antigen (DU-PAN-2) in sera of patients with non-malignant hepatobiliary diseases and hepatomas.
Haviland AE; Borowitz MJ; Killenberg PG; Lan MS; Metzgar RS
Int J Cancer; 1988 Jun; 41(6):789-93. PubMed ID: 2836318
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis.
Tajiri T; Tate G; Kunimura T; Endo Y; Inoue K; Mitsuya T; Morohoshi T; Yoshiba M
Dig Dis Sci; 2005 Jan; 50(1):188-95. PubMed ID: 15712659
[TBL] [Abstract][Full Text] [Related]
20. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
Ward SC; Huang J; Tickoo SK; Thung SN; Ladanyi M; Klimstra DS
Mod Pathol; 2010 Sep; 23(9):1180-90. PubMed ID: 20495535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
